Norwich, UK –
Sustainable Rubber Alternative Gains Traction
UK biotechnology company QuberTech has successfully secured £3.4 million in a funding round that includes both grant funding and equity investment. This significant financial injection is earmarked for the advancement of its innovative dandelion-based natural rubber (NR) platform and the scaling of its commercial operations. The company announced the closure of this funding on May 26, 2026. The investment underscores a growing interest in sustainable and resilient material sourcing within the UK's burgeoning biotech sector.
Addressing Global Supply Chain Vulnerabilities
QuberTech's core technology focuses on developing engineered dandelion strains capable of producing high-quality natural rubber and other bio-based materials within controlled growing environments. This approach aims to provide a crucial alternative to conventional rubber supply chains, which are predominantly located in tropical regions and are inherently vulnerable to climate change, disease outbreaks, and geopolitical instability. The company's research integrates cutting-edge plant biotechnology, genome editing, and scaling transformative technologies from laboratory concepts to commercial reality. The strategic importance of securing resilient and sustainable access to critical industrial materials like natural rubber is paramount in the current global economic climate. QuberTech’s CEO, Dr. Ofir Meir, highlighted the increasing pressure on global natural rubber supply chains and the necessity for countries to ensure more dependable access to this vital resource.
Government Support and Future Expansion
In addition to private investment, QuberTech has also garnered support from the UK government through Defra's Farming Innovation Programme, which is administered in partnership with Innovate UK. This dual support highlights both market confidence and public sector recognition of the project's potential impact. The company's research is concentrated on cultivating high-yield dandelion varieties that can efficiently produce NR, alongside other biomaterials suitable for a range of applications including packaging, cosmetics, and food products. Dr. Meir stated that the newly acquired funds will be instrumental in accelerating research and development activities, expanding the company's expert team, and validating the technology at a pilot scale. He further emphasized QuberTech's mission to develop a new generation of sustainable biomaterials, leveraging engineering biology to create resilient, locally produced alternatives to imported natural rubber. Oliver Sexton, Investment Director at UKI2S, commented on the vulnerability of global NR supply chains, endorsing QuberTech's approach as a significant step towards greater supply chain security and sustainability. The company’s strategic location in Norwich, UK, positions it well to capitalize on the nation's growing focus on green innovation and advanced manufacturing.